Review examines safety questions around cultivated meat

Version 2

A new review in Physiological Research takes on one of the central questions surrounding cultivated meat: not whether it is novel, but whether it can be made safely at scale. The authors conclude that cultivated meat has a credible safety case when compared with conventional meat production, while emphasizing that several areas, including contamination control, cell-line stability, media composition, allergenicity, and nutritional consistency, still need more evidence and tighter standardization. (visualize.jove.com)

That framing matters because cultivated meat has moved beyond theory and into active regulatory oversight. In the U.S., FDA and USDA-FSIS share responsibility under a formal framework established in March 2019. FDA oversees cell collection, cell banks, and cell growth and differentiation, then USDA-FSIS assumes oversight at harvest for livestock and poultry products, including inspection, processing, and labeling. FDA says its pre-market consultation process evaluates the production process, cell lines, manufacturing controls, and inputs before products enter the market. (fda.gov)

The review appears to fit squarely within that regulatory logic. Rather than presenting cultivated meat as risk-free, it maps the main hazards that would need to be controlled, especially microbial contamination, the biological behavior of cell lines over time, the use of immortalized or genetically modified cells, and the safety of growth media and other processing inputs. That aligns with broader international work from FAO and WHO, which has said cell-based foods raise distinct food-safety questions that should be addressed through hazard identification and risk-based oversight, not assumptions either for or against the technology. (visualize.jove.com)

Industry and food-safety experts are also pushing the discussion in that direction. A 2026 expert perspective published through the International Association for Food Protection said the sector needs more information sharing, stronger ingredient specifications, and clearer safety standards, with recurring concerns around novel hazards and spore-forming microorganisms. Another recent review highlighted microbial contamination, adventitious agents, genomic instability, and tumorigenicity as priority hazards for food-safe cell lines and banks. Taken together, the message is that the debate is shifting from “Is cultivated meat safe in principle?” to “What controls, validation, and surveillance will make specific products safe in practice?” (foodprotection.org)

For veterinary professionals, that distinction is especially relevant. Even when cultivated meat is discussed mainly as a human-food story, the regulatory and scientific issues spill into animal health and nutrition. FDA notes that if cultured animal cell products or byproducts are intended for animal food, firms should work with the Center for Veterinary Medicine, and the broader federal biotechnology framework explicitly places cultured animal cell products for animal food under FDA-CVM oversight. For veterinarians in practice, industry, toxicology, or nutrition, that means future questions may extend beyond consumer acceptance to ingredient sourcing, digestibility, allergen profiles, manufacturing consistency, and how novel proteins are incorporated into companion animal diets. (fda.gov)

There’s also a useful comparison here with conventional meat production. The new review’s title signals that safety concerns shouldn’t be examined in a vacuum. Conventional meat systems already manage known hazards, including pathogens, residues, and processing contamination, through inspection and HACCP-based controls. Cultivated meat may reduce some exposure points associated with slaughter and carcass handling, but it introduces different control points tied to sterile processing, cell banking, bioreactor operations, and media inputs. The practical question for veterinarians and food-safety professionals is not which system is abstractly “cleaner,” but which hazards are most likely in each system and how reliably they can be prevented, detected, and corrected. That’s an inference drawn from the regulatory framework and expert roadmaps, which increasingly treat cultivated meat as a process-control challenge. (fda.gov)

Why it matters: This paper adds to a growing body of literature that could help normalize a more disciplined, less polarized discussion of cultivated meat safety. For veterinary audiences, that’s useful because the profession often sits at the intersection of food safety, animal agriculture, public health, and companion animal nutrition. If cultivated proteins eventually move into treats, therapeutic diets, or broader pet food applications, veterinarians may be asked to interpret safety claims long before the evidence base is complete. Reviews like this one help define the right questions: What is the source and stability of the cells? What are the inputs? How are contaminants controlled? What data support nutritional adequacy and allergen risk? (visualize.jove.com)

What to watch: The next milestones will likely be more detailed product-specific regulatory dossiers, clearer standards for cell banks and media ingredients, and any visible movement on cultivated ingredients for animal food, where FDA-CVM’s role could become more prominent. (fda.gov)